Valuation: Adocia

Capitalization 12Cr 14Cr 11Cr 10Cr 19Cr 1.25TCr 21Cr 126.68Cr 50Cr 593.92Cr 51Cr 50Cr 2.17TCr P/E ratio 2025 *
3.18x
P/E ratio 2026 * 7.79x
Enterprise value 4.12Cr 4.77Cr 3.83Cr 3.57Cr 6.64Cr 433.19Cr 7.15Cr 44Cr 17Cr 206.63Cr 18Cr 18Cr 754.51Cr EV / Sales 2025 *
1.07x
EV / Sales 2026 * 0.43x
Free-Float
80.99%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.48%
1 week-4.53%
Current month-11.94%
1 month-10.20%
3 months-37.43%
6 months+35.17%
Current year-11.94%
More quotes
1 week 5.86
Extreme 5.86
6.32
1 month 5.85
Extreme 5.85
6.91
Current year 5.85
Extreme 5.85
6.91
1 year 2.86
Extreme 2.86
12.4
3 years 2.74
Extreme 2.745
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
65.53
More quotes
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 60 18/06/2013
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.48%-4.53%-2.32%+39.64% 14Cr
-1.53%+1.67%+7.66%+92.83% 4.92TCr
+0.71%+5.27%+96.79%+10.10% 4.46TCr
+1.35%-8.27%+122.62%+761.37% 3.44TCr
+2.76%+9.16%-2.62%-23.82% 2.74TCr
-4.83%+0.75%+102.46%-46.22% 2.11TCr
-6.41%-5.32%+35.56%-24.41% 2.09TCr
-3.06%-6.98%+96.15%+150.64% 1.43TCr
-5.45%-8.38%+167.14% - 1.42TCr
-1.33%-13.41%-10.46%+282.92% 1.31TCr
Average -2.03%-0.42%+61.30%+138.12% 2.39TCr
Weighted average by Cap. -1.24%+0.50%+64.15%+155.30%
See all sector performances

Financials

2025 *2026 *
Net sales 3.84Cr 4.45Cr 3.57Cr 3.33Cr 6.2Cr 404.08Cr 6.67Cr 41Cr 16Cr 192.75Cr 17Cr 16Cr 703.81Cr 3.84Cr 4.45Cr 3.57Cr 3.33Cr 6.19Cr 404.01Cr 6.66Cr 41Cr 16Cr 192.71Cr 17Cr 16Cr 703.68Cr
Net income -1.03Cr -1.2Cr -96.16L -89.52L -1.67Cr -108.71Cr -1.79Cr -11Cr -4.36Cr -52Cr -4.49Cr -4.4Cr -189.34Cr 1.4Cr 1.62Cr 1.3Cr 1.21Cr 2.25Cr 146.97Cr 2.42Cr 15Cr 5.9Cr 70Cr 6.07Cr 5.95Cr 255.98Cr
Net Debt -7.71Cr -8.95Cr -7.18Cr -6.69Cr -12Cr -811.92Cr -13Cr -83Cr -33Cr -387.28Cr -34Cr -33Cr -1.41TCr -10Cr -12Cr -9.49Cr -8.83Cr -16Cr -1.07TCr -18Cr -109.15Cr -43Cr -511.72Cr -44Cr -43Cr -1.87TCr
More financial data * Estimated data
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2024, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
77
More about the company
Date Price Change Volume
19/26/19 5.900 -2.48% 1,78,240
16/26/16 6.050 -0.98% 1,92,535
15/26/15 6.110 -0.97% 1,41,617
14/26/14 6.170 +2.32% 2,14,576
13/26/13 6.030 -2.43% 1,69,405

Real-time Euronext Paris, January 19, 2026 at 06:12 pm IST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.050EUR
Average target price
14.00EUR
Spread / Average Target
+131.40%
Consensus

Annual profits - Rate of surprise